Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

ambrx biopharma inc.

POPULAR ARTICLES

Ambrx Biopharma Inc. Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price

Ambrx Biopharma Inc. Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price

Ambrx Announces Encouraging Preliminary Safety and Efficacy Data Evaluating ARX788 in HER2 Positive Metastatic Breast Cancer Patients Who Progressed Following T-DM1 Treatment

Ambrx Announces Encouraging Preliminary Safety and Efficacy Data Evaluating ARX788 in HER2 Positive Metastatic Breast Cancer Patients Who Progressed Following T-DM1 Treatment

Interim Data from Ambrx's Study of ARX788 selected for Spotlight Poster Discussion at the 2022 San Antonio Breast Cancer Symposium

Interim Data from Ambrx's Study of ARX788 selected for Spotlight Poster Discussion at the 2022 San Antonio Breast Cancer Symposium

LATEST ARTICLES

Ambrx Announces NovoCodex's Dosing of First Patient with ARX305, Ambrx's Investigational Antibody Drug Conjugate Targeting CD70

Ambrx Announces NovoCodex's Dosing of First Patient with ARX305, Ambrx's Investigational Antibody Drug Conjugate Targeting CD70

Ambrx Biopharma Inc. Appoints Daniel O'Connor as Chief Executive Officer

Ambrx Biopharma Inc. Appoints Daniel O'Connor as Chief Executive Officer

Ambrx Biopharma Inc. Announces Strategic Reprioritization and Provides Corporate Update

Ambrx Biopharma Inc. Announces Strategic Reprioritization and Provides Corporate Update

Ambrx Biopharma to Host Corporate Update Conference Call

Ambrx Biopharma to Host Corporate Update Conference Call

Ambrx Biopharma Inc. Reports 1H 2022 Financial Results and Provides Corporate Update

Ambrx Biopharma Inc. Reports 1H 2022 Financial Results and Provides Corporate Update

Ambrx Biopharma Appoints Kate Hermans as Interim CEO, Replacing Feng Tian

Ambrx Biopharma Appoints Kate Hermans as Interim CEO, Replacing Feng Tian

Ambrx Biopharma Appoints Edward Hu and Kate Hermans to its Board of Directors

Ambrx Biopharma Appoints Edward Hu and Kate Hermans to its Board of Directors

Ambrx Biopharma Inc. to Present at the H.C. Wainwright Preclinical Cancer Drug Discover Conference

Ambrx Biopharma Inc. to Present at the H.C. Wainwright Preclinical Cancer Drug Discover Conference

Latest News

Questcorp Mining Provides Clarification on Sharing Arrangement

Flow Metals Announces Closing of Shares for Debt

Forte Minerals Corp. Amendment to Investor Relations Compensation

Angkor Resources Announces AGM Results and Appointment of New Director

Nuvau Minerals Announces up to $20 Million Brokered Private Placement

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Lahontan Gold Corp.

Lahontan Gold Corp. (LG:CC)

LG:CC

Homeland Nickel

Homeland Nickel (SHL:CC)

SHL:CC

Sranan Gold

Sranan Gold (SRAN:CC)

SRAN:CC

Mayfair Gold Corp.

Mayfair Gold Corp. (MFG:CC)

MFG:CC

New Found Gold

New Found Gold (NFG:CC)

NFG:CC

Coelacanth Energy

Coelacanth Energy (CEI:CC)

CEI:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES